Third Party IP Payments definition

Third Party IP Payments has the meaning set forth in Section 10.6.3(b).
Third Party IP Payments is defined in Section 7.3.6 (By Company).
Third Party IP Payments means any and all upfront payments, milestone payments, royalties, and other amounts paid to a Third Party under a Collaboration In-License to the extent solely attributable to Collaboration Products; provided, that Third Party IP Payments do not include any Third Party Fc Royalty Payments.

Examples of Third Party IP Payments in a sentence

  • Within sixty (60) business days of the date of such notice or, should a Third Party provide a shorter response time, within such time (provided however that in no event shall Orion be given a shorter time than five (5) business days to begin discussions and ten (10) business days to provide full comments), Orion shall discuss with Licensee, in good faith, the Third Party IP and the proposed Third Party IP Payments specified in such notice.

  • Thereafter, Jazz shall be solely responsible for any New Third Party IP Payments due to the applicable Third-Party licensor if such New Domain is used by Jazz or its Affiliates or Sublicensees in a Licensed Product and Jazz took a sublicense to the applicable New Third Party IP.

  • For clarity, if any Third Party IP Payments are payable partially on the basis of a Financial Product hereunder and partially on the basis of one or more other products owned or controlled by Gilead, then the amount of offset under this Section 9.7(c)(iv) (Third Party IP Payments) shall be limited to a reasonable allocation of Third Party IP Payments attributable to Net Sales of Financial Products.

  • Any portion of the Third Party IP Payments payable to such Third Party with respect to such Licensed Product in such country that Flame would, but for the foregoing limitation on royalty reductions, be entitled to deduct under Section 4.5 shall be (***).

  • Any damages assessed to Novo Nordisk as a result of an infringement defense action and any costs, expenses, or consideration paid by or on behalf of Novo 47 Nordisk in connection with undertaking a license or settlement in order to remedy, cure, settle, or avoid such (potential) infringement pursuant to this Section 8.8 (Third Party Rights) will be deemed Third Party IP Payments to Third Parties eligible for offset by Novo Nordisk pursuant to Section 7.6.3 (Third Party Payments).


More Definitions of Third Party IP Payments

Third Party IP Payments means royalties (whether in the form of actual royalties or guaranteed minimum royalties) or other payments agreed to by the Parties.
Third Party IP Payments has the meaning set forth in Section 7.6.3 (Third Party Payments). 1.179. “U.S.” or “United States” means the United States of America and its possessions and territories, including Puerto Rico. 1.
Third Party IP Payments means any amounts paid by a Party or any of its Affiliates under any Third Party IP License that are reasonably allocable to the Products.
Third Party IP Payments means (a) if Novartis or any of its Affiliates is a party to an agreement with a Third Party for a license or other right to any Third Party IP Rights with respect to a Collaboration Compound or Collaboration Product in one or more countries in the Territory, upfront payments, milestone payments, royalties, and other consideration paid to such Third Party in respect of such agreement, in each case in this clause (a), to the extent reasonably allocable to such Third Party IP Rights in such country(ies), (b) if Novartis agrees to pay any amounts to a Third Party in order to obtain a sublicense or other right to any Third Party IP Rights with respect to a Collaboration Compound or Collaboration Product in one or more countries in the Territory pursuant to Section 8.5(c)(iii)(B)(2)8.5(c)(iii)(B)(2), such amounts or (c) if Novartis defends an infringement claim pursuant to Section 9.6 (Third Party Rights) in the Territory with respect to a Collaboration Compound or Collaboration Product, reasonable out-of-pocket costs of defending or settling such infringement claim pursuant to Section 9.6 (Third Party Rights) that are borne by Novartis or its Affiliates and its Sublicensees (including royalties, milestones and other consideration paid and any damages or other awards assessed in connection therewith).